Regulation of extracellular ATP of human erythrocytes treated with α-hemolysin: Effects of cell volume, morphology, rheology and hemolysis by Leal Denis, Maria Florencia et al.
Accepted Manuscript
Regulation of extracellular ATP of human erythrocytes treated
with α-hemolysin. Effects of cell volume, morphology, rheology
and hemolysis
M.F. Leal Denis, S.D. Lefevre, C.L. Alvarez, N. Lauri, N.
Enrique, D.E. Rinaldi, R. Gonzalez-Lebrero, L.E. Vecchio, M.V.





To appear in: BBA - Molecular Cell Research
Received date: 2 November 2018
Revised date: 10 January 2019
Accepted date: 30 January 2019
Please cite this article as: M.F.L. Denis, S.D. Lefevre, C.L. Alvarez, et al., Regulation of
extracellular ATP of human erythrocytes treated with α-hemolysin. Effects of cell volume,
morphology, rheology and hemolysis, BBA - Molecular Cell Research, https://doi.org/
10.1016/j.bbamcr.2019.01.018
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may














Regulation of extracellular ATP of human erythrocytes treated with α-
hemolysin. Effects of cell volume, morphology, rheology and hemolysis. 
 
M.F. Leal Denisa,b, S.D. Lefevrec,d, C.L. Alvareza,e, N. Lauria,f, N. Enriqueg,h, D.E. Rinaldia,i, R. 
Gonzalez-Lebreroa,i, L.E. Vecchiog,h, M.V. Espelta,f, P. Stringag,j,k, C. Muñoz-Garayl, V. Milesig,h, 
M.A. Ostunic,d, V. Herlaxm,n, P.J. Schwarzbauma,f^. 
 
aUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de 
Química y Fisico-Química Biológicas (IQUIFIB) “Prof. Alejandro C. Paladini”. Facultad de Farmacia y 
Bioquímica, Junín 956. Buenos Aires, Argentina. 
bUniversidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Analítica. 
Cátedra de Química Química Analítica y Fisicoquímica, Junín 956. Buenos Aires, Argentina. 
cUMR-S1134, Integrated Biology of Red Blood Cells, INSERM, Université Paris Diderot, Sorbonne Paris 
Cité, Université de la Réunion, Université des Antilles, F-75015 Paris, France. 
dInstitut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, F-75015 Paris, France; 
eUniversidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Biodiversidad 
y Biología Experimental, Intendente Güiraldes 2160. Buenos Aires, Argentina. 
fUniversidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Biológica. 
Cátedra de Química Biológica Superior, Junín 956. Buenos Aires, Argentina. 
gUniversidad Nacional de La Plata. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto 
de Estudios Inmunológicos y Fisiopatológicos (IIFP). Facultad de Ciencias Exactas, Calle 47 y 115. La 
Plata, Argentina. 
hUniversidad Nacional de la Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. 
Cátedra de Fisiología, Calle 47, Casco Urbano. La Plata, Argentina. 
iUniversidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Biológica. 
Cátedra de Química Biológica, Junín 956. Buenos Aires, Argentina. 
jUniversidad Favaloro. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina 
Traslacional, Trasplante y Bioingeniería (IMETTyB), Av. Entre Ríos 495. Buenos Aires, Argentina. 
kUniversidad Nacional de La Plata. Laboratorio de Trasplante de Órganos y Tejidos. Facultad de Ciencias, 
Calle 60 y 120. La Plata, Argentina. 
lInstituto de Ciencias Físicas, Universidad Nacional Autónoma de México (UNAM), Av. Universidad s/n. 
Cuernavaca, México. 
mUniversidad Nacional de La Plata. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto 
de Investigaciones Bioquímicas de La Plata (INIBIOLP) "Prof. Dr. Rodolfo R. Brenner". Facultad de 
Ciencias Médicas, Av. 60 y Av. 120. La Plata, Argentina. 
nUniversidad Nacional de La Plata. Facultad de Ciencias Médicas, Av. 60 y Av. 120. La Plata, Argentina. 
 
^To whom correspondence should be addressed. 
Pablo Julio Schwarzbaum, Ph.D., Facultad de Farmacia y Bioquímica, Universidad de Buenos 
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Abstract 
Alpha-hemolysin (HlyA) of uropathogenic strains of Escherichia coli irreversibly binds to human 
erythrocytes (RBCs) and triggers activation of ATP release and metabolic changes ultimately 
leading to hemolysis. 
We studied the regulation of extracellular ATP (ATPe) of RBCs exposed to HlyA. Luminometry 
was used to assess ATP release and ATPe hydrolysis, whereas changes in cell volume and 
morphology were determined by electrical impedance, ektacytometry and aggregometry. 
Exposure of RBCs to HlyA induced a strong increase of [ATPe] (3-36-fold) and hemolysis (1-44-
fold), partially compensated by [ATPe] hydrolysis by ectoATPases and intracellular ATPases 
released by dead cells. Carbenoxolone, a pannexin 1 inhibitor, partially inhibited ATP release 
(43-67 %). 
The un-acylated toxin ProHlyA and the deletion analog HlyA∆914-936 were unable to induce 
ATP release or hemolysis. 
For HlyA treated RBCs, a data driven mathematical model showed that simultaneous lytic and 
non-lytic release mainly governed ATPe kinetics, while ATPe hydrolysis became important after 
prolonged toxin exposure. 
HlyA induced a 1.5-fold swelling, while blocking this swelling reduced ATP release by 77 %. 
Blocking ATPe activation of purinergic P2X receptors reduced swelling by 60-80 %. HlyA-RBCs 
showed an acute 1.3-2.2-fold increase of Ca2+i, increased crenation and externalization of 
phosphatidylserine. Perfusion of HlyA-RBCs through adhesion platforms showed strong 
adhesion to activated HMEC cells, followed by rapid detachment. HlyA exposed RBCs exhibited 
increased sphericity under osmotic stress, reduced elongation under shear stress, and very low 
aggregation in viscous media. 
Overall results showed that HlyA-RBCs displayed activated ATP release, high but weak 
adhesivity, low deformability and aggregability and high sphericity. 
 


















Human erythrocytes (RBCs) can release ATP when exposed to beta-adrenergic stimulation, 
mechanical deformation, cell adhesion, blood flow turbulence, hypoxia or acidosis (1,2). These 
treatments mimic several conditions to which RBCs are exposed in the vasculature, e.g. when 
passing microvascular beds or the contracting skeletal muscle (3–6).  
A reduction of ATP release from RBCs has been associated with diseases such as type II 
diabetes and cystic fibrosis (7–9), while RBCs infection with Plasmodium falciparum or 
exposure to bacterial α-hemolysin correlated with activation of ATP release (10,11). 
Intracellular ATP can be released by hemolysis (12) and/or by regulated transport (13). 
Candidate conduits for regulated ATP release in these cells include several anionic channels 
(VDAC, maxi anions, volume regulated ion channel and tweety, (13–16), and pore forming 
proteins like pannexin 1 (pnx1) and P2X7 purinergic receptor (17,18). In addition, α-hemolysin 
(HlyA) was shown to activate ATP exit of RBCs, presumably by forming pores through which 
the nucleotide transverses the plasma membrane (10,19).  
HlyA is an exotoxin secreted by some pathogenic strains of E. coli that causes lysis of several 
mammalian cells, including RBCs from humans and other mammalian species (20). In vivo HlyA 
has been associated with urinary tract infections and septicemia (21,22). HlyA is synthesized as 
the protoxin ProHlyA, which is activated by acylation at two internal lysines, Lys-563 and Lys-
689. Acylation turns binding of the toxin to the cell membrane irreversible, initiating a series of 
events leading to hemolysis (23).  
The mechanisms enabling ATP release by HlyA are scarcely known, and the putative existence 
of a receptor for the toxin in erythrocytes remains controversial (24,25). Toxin recognition of 
RBCs appears to require a short sequence from the C-terminal domain (aminoacid residues 
914-936) capable of binding to glycophorins at the RBC surface (26). A deletion mutant lacking 
these residues lacked hemolytic activity (26), but its effects on ATP release were not tested. 
On the other hand, while it has been suggested that during HlyA exposure an early non-lytic 
ATP release precedes hemolysis (10), parallel dynamic changes in cell volume (Vt) and 
morphology of RBCs were observed, with unknown consequences on extracellular ATP (ATPe) 
homeostasis. This is important inasmuch as the extent of ATP release from RBCs, activated by 
different stimuli, was shown to depend on the capacity of these cells to swell or deform, both 
in physiological as well as pathological contexts (2,27).  
In addition to ATP release, other processes may control ATPe regulation. On the one hand, 
increased [ATPe], caused by activated ATP exit, can be partly compensated by ectoATPase 
activity by one or more ectonucleotidases of RBCs and –in vivo- of other blood and vascular 
cells (28). The activities of these enzymes generate extracellular accumulation of ADP and 
adenosine which, together with ATPe, constitute potent ligands capable of activating 
purinergic receptors functionally expressed in RBCs (29,30) and endothelial cells (31).  
The physiological effects of such ligand-receptor interactions can be manifold. In RBCs, P2X7 
activation by ATPe promoted hemolysis (19), a process which should lead to lytic ATP release. 
In the absence of hemolysis, we found that ATPe activation of P2X2 triggered swelling 
dependent ATP release (32,33). On the other hand, accumulation of extracellular ADP from 
ATPe, due to ectonucleotidase activity, led to activation of P2Y13 coupled to inhibition of ATP 
release (29,33). Thus ATPe regulation depends on the dynamic interaction among ATP release 
















In this study we characterized how these processes affect ATP regulation of RBCs exposed to 
HlyA and structural toxin analogs. We made a quantitative assessment of ATPe kinetics, 
together with a comprehensive description of the main processes controlling HlyA dependent 
ATP regulation of RBCs. Additionally, we tested the interaction between HlyA and RBCs under 
different conditions resembling physio-pathological contexts. I.e., ATPe regulation of RBCs was 
assessed when cells were perfused through a rat mesenteric vascular bed, and video/electron 
microscopies and rheological techniques were used to assess the capacity of HlyA treated RBCs 

















2. Materials and Methods 
All reagents in this study were of analytical grade. Bovine serum albumin (BSA), 
carbenoxolone, digitonin, sucrose,  A438079, A740003, human haemoglobin, apyrase (EC 
3.6.1.5), firefly luciferase (EC 1.13.12.7), guanidinium hydrochloride, ionomycin, A23175, ATP 
and dextran 400 were purchased from Sigma (St. Louis, MO, USA). The BCECF-AM, Fluo4-AM, 
D-luciferin, bis-(1,3-dibutylbarbituric acid)trimethine oxonol (DiBAC4(3)) were purchased from 
Invitrogen/Molecular Probes Inc. (Eugene, OR, USA). NF110 was purchased from TOCRIS 
(Bristol, United Kingdom). 
 
2.1 Media used 
Tris-Chloride (TC) buffer (in mM) 20 Tris, 150 NaCl, pH 7.4 at 25 °C.  
Isosmotic medium (in mM) 137 NaCl, 2.7 KCl, 2.5 Na2HPO4, 1.50 KH2PO4, 1.32 CaCl2, 1.91 
MgSO4, 5 glucose, pH 7.4 at 25 °C, 300 mosM and supplemented with 0.1 % BSA.  
Hyperosmotic medium (in mM) 137 NaCl, 2.7 KCl, 4.72 Na2HPO4, 1.50 KH2PO4, 1.32 CaCl2, 1.91 
MgSO4, 5 glucose, 30 mM sucrose, pH 7.4 at 25 °C, 325 mosM and supplemented with 0.1 % 
BSA. 
Krebs Ringer solution (in mM): 130 NaCl, 4.7 KCl, 1.17 Na2HPO4, 1.16 MgSO4, 24.0 mM NaHCO3, 
2.5 CaCl2, 6 glucose, pH 7.4 at 25 °C. 
 
2.2 Isolation of human erythrocytes 
Immediately after blood collection, plasma, platelets and leukocytes were removed by 
centrifugation (900 x g at 20 °C for 3 min). The supernatant and buffy coat were removed and 
discarded. Isolated red blood cells (RBCs) were resuspended and washed three times in 
isosmotic medium. Packed RBCs were resuspended in isosmotic medium to the corresponding 
final hematocrit. 
 
2.3 Liposomes preparation 
Large unilamellar vesicles (LUVs) of 100 nm were made of palmitoyl-oleoyl-
phosphatidylcholine:sphingomyelin:cholesterol (POPC:SM:CHO) in a molar ratio of 2:1:1. They 
were prepared by mixing the appropriate amount of synthetic pure lipids dissolved in 
chloroform/methanol (2:1, v/v). Samples were dried under a stream of nitrogen and then 
placed at high vacuum for 2 h in a glass chamber connected to a vacuum pump. Samples were 
then hydrated in isosmotic medium containing 50 mM ATP, and exposed to 10 rounds of 
freezing- thawing before extrusion (10 times) through 100 nm filters in a mini extruder 
(Avestin, Canada). Non-encapsulated ATP was removed by exclusion chromatography (PD-10, 
GE Healthcare).  
 
2.4 Purification of HlyA, ProHlyA and HlyA916-934 
Different E. coli overproducing strains were used to produce and release HlyA and mutants. E. 
coli WAM1824 (E.coli JM15 strain transformed with pSF4000) produced and release HlyA (34) 
and E.coli WAM 783 (E.coli DH1 strain transformed with pSF4000ΔΒamΗI, in which a portion of 
the hlyC gene has been deleted) produced the un-acylated inactive protein ProHlyA (35).  
Both E. coli strains were gently provided by Dr. Welch (University of Wisconsin Medical School, 
















936, i.e., a deletion HlyA mutant lacking 914–936 residues. The plasmid was gently given by Dr. 
Ostolaza (Universidad del País Vasco, Bilbao, Spain). 
All cultures were grown over night at 37 °C in Luria–Bertani medium to late log phase (D600nm= 
0.9–1.0). The HlyA∆914-93 producing strain was induced by 0.4 mM IPTG when 0.6 D was 
reached. Bacteria were then pelleted, and the supernatants concentrated and partially purified 
by precipitation with 20 % (v/v) cold ethanol at pH 4.5. Pellets containing HlyA, ProHlyA or 
HlyA∆914-936 were collected by centrifugation (14,500 x g at 20 °C for 1 h, Sorvall centrifuge 
rotor SSA 34) and then resuspended in TC buffer supplemented with 6 M guanidinium 
hydrochloride. SDS-PAGE gels of these preparations showed a main band at 110 kDa 
corresponding to more than 90 % of the total protein (Suppl. Fig. 1 A). Protein content of each 
sample was determined by Bradford (36). To evaluate protein functionality, its hemolytic 
activity was determined as described below. The resulting proteins were stored at −70 °C in 
guanidinium hydrochloride. 
Throughout text, RBCs exposed to HlyA ProHlyA and HlyAΔ914-936 were denoted as HlyA-
RBCs Pro-RBCs and HlyAΔ914-936-RBCs, respectively. Untreated RBCs (i.e., controls) were 
denoted as c-RBCs. 
 
2.5 Hemolytic assays 
Two sets of hemolytic assays were carried out. The first assay evaluated the functionality of 
the HlyA after purification, while the second assay was performed to establish the HlyA 
concentration used in experiments with RBCs.  
To evaluate HlyA functionality, its hemolytic activity was determined by light scattering of a 
RBCs suspension exposed to increasing concentrations of the toxin. Briefly, 100 μL of HlyA 
stock solution was serially diluted in isosmotic buffer (0-69 ng/μL) in a 96-well microtiter plate 
and mixed with 100 μL of RBCs suspension (3 % hematocrit). The plate was then incubated at 
37 °C for 30 min and the absorbance at 600 nm measured with a Multimode Detector DTX 880 
Beckman Coulter (Suppl. Fig. 1 B).  
To establish the concentration of HlyA to be used in experiments, the hemolytic activity was 
determined by measuring hemoglobin concentration of the supernatants of RBCs suspensions 
exposed to increasing concentrations of HlyA. Briefly, 100 μL of RBCs suspension (20 % 
hematocrit) was added to 100 μL of serial 2-fold dilutions of HlyA (0.5-138 ng/μL) in a 
microtiter plate. The plate was incubated at 37 °C for 5 min, the suspensions were then 
collected and centrifuged (12600 x g at 20 °C for 30 s) and the hemolysis was quantified as 
released hemoglobin by measuring absorbance at 405 nm. Results were expressed as 
percentage of hemolyzed RBCs (% Hemolysis) as function of HlyA concentration (in log scale) 
(Suppl. Fig. 1 C). Except otherwise stated, an HlyA concentration producing 0.5 % hemolysis 
after 5 min was used for most experiments (4.5-5 ng/μL). For experiments using ProHlyA and 
HlyA∆914-936, a 10-fold higher concentration than that used for HlyA was used. 
 
2.6 ATP measurements 
Extracellular ATP (ATPe) and intracelular ATP (ATPi) were measured using firefly luciferase, 
which catalyzes the oxidation of luciferin in the presence of ATP to produce light (37,38). 
Because luciferase activity at 37° C is only 10 % of that observed at 20 °C (39), to maintain full 
luciferase activity, ATP measurements were performed in a cool chamber of a custom-built 
















change during the course of the experiment. Two different types of luminometry 
determinations were performed, off-line and on-line. 
2.6.1 Off-line measurements 
For off-line luminometry determinations, ATPe was measured as previously described 
(7,8,32,40,41). Briefly, 100 L of 20 % RBCs suspension were exposed at 37 °C to 100 L of 
HlyA in iso- or hyperosmotic media, in the absence and presence of different blockers. 
Afterwards, 1.5 μL of the suspension was diluted in 45.5 µL of isosmotic medium (final 
hematocrit 0.32%) to quantify [ATPe] at different times of toxin exposure. Light emission was 
transformed into ATPe concentration by means of a calibration curve. That is, at the end of 
each experiment ATP from 2 to 10 μM was sequentially added to the assay medium from a 
stock solution of pure ATP dissolved in RBC medium. Hemolysis was assessed in paired samples 
(see method below). The presence of free hemoglobin originated from the hemolysis of RBCs 
did not interfere with the luminometric signal (not shown). Results were expressed as ATPe in 
µM. 
2.6.2 On-line measurements 
On-line luminometry measurements were carried out with ATP-loaded liposomes, similarly to 
experiments with RBCS performed before (33). Briefly, liposomes (1.7x1010, 1.7x1011 or 
2.5x1011) were laid on coverslips mounted in the assay chamber of the luminometer, incubated 
with 40 μL of luciferin-luciferase mix reaction and exposed to different concentrations of HlyA. 
Under the experimental conditions, assay volume did not change during the course of the 
experiment. In separate experiments, liposomes were permeabilized with digitonin (300 
μg/mL) to induce full ATP release. Light emission was transformed into ATPe concentration vs. 
time by means of a calibration curve for each experiment, where increasing concentrations of 
ATP from 0.5 to 10 μM were sequentially added to the assay medium from a stock solution of 
pure ATP dissolved in RBC medium. Results were expressed as [ATPe] at every time point of a 
kinetic curve, with [ATPe] expressed as µM (Suppl. Fig. 2). Alternatively, increases in [ATPe] 
were evaluated at 20 min post stimulus. 
Additionaly, on-line luminometry measurements were performed to estimate [ATPi] as 
describe previously (42). Briefly, RBCs (1.0x105) were laid on coverslips, incubated with 45 μL 
of luciferine-luciferase mix reaction for 5 min and permeabilized with digitonin (50 μg/mL). 
Light emission was transformed into ATPe concentration vs. time by means of a calibration 
curve for each experiment, as described above. After considering the total volume occupied by 
RBCs present in the chamber, and the relative solvent cell volume, intracellular ATP (ATPi) 
amounted to 2.02 ±0.10 (N=15). 
 
2.7 Hemoglobin measurements 
For each sample taken to assess ATPe by off-line luminometry, a paired sample was taken to 
assess hemolysis. Accordingly, paired samples were centrifuged at 12600 x g and 20 °C for 30 
sec and the presence of free hemoglobin in the supernatant was determined by light 
absorption at 405 nm. Results are expressed as percentage of hemolyzed RBCs (% Hemolysis) 
with respect to the total number of RBCs. 
 
















Intracellular ATPase activity was determined by off-line luminometry, following the decrease of 
exogenous ATP added to a lysate of RBCs. Briefly, 2x106 and 1x107 RBCs were lysed in a 
medium with 1 mM PMSF and incubated with ATP (1 to 120 μM) at 37 °C. [ATP] was measured 
in 1.5 μL aliquots by off-line luminometry after 5 and 10 min of ATP addition. Recorded light 
output was transformed into ATPe concentration by means of a calibration curve. To calculate 
intracellular ATPase activity, linear functions were fitted to experimental data and the 
parameters of best fit resulting from the regression were used to calculate the initial rates of 
ATPe extinction (i.e., intracellular ATPase activity). Results were expressed as μM/min. 
 
2.9 Ecto-ATPase activity 
EctoATPase activity was determined by off-line luminometry, following the decrease of 
exogenous ATP added to a suspension of intact RBCs. Briefly, 200 μL RBCs suspensions of 10 % 
hematocrit (containing approx. 2.22x108 cells) were incubated with ATP (2 to 153 μM) at 37 °C. 
ATPe concentration was measured in 1.5 μL aliquots of the suspension every 2 min for 10 min. 
Recorded light output was transformed into ATPe concentration by means of a calibration 
curve. Linear functions were fitted to experimental data and the parameters of best fit were 
used to calculate initial rates of ATPe extinction, a measure of EctoATPase activity. Paired 
samples were collected for parallel hemolysis assessment, so as to estimate and subtract ATPe 
consumption due to intracellular ATPase activity of lysed cells. Results were expressed as 
μM/min. 
 
2.10 Apyrase activity 
Apyrase activity was assessed by on-time luminometry, following the decay of ATP solutions 
after addition of apyrase. Briefly, 1 μL of ATP solutions ranging from 0.03 to 30 μM were added 
to 45 μL of luciferin-luciferase mix reaction and ATP kinetics was measured on-line as 
described above. After attaining a stable signal, 1 μL of apyrase (2 to 80 U/mL) was added and 
luminiscence decay was continuously monitored for 2 min. Recorded light output was 
transformed into ATPe concentration by means of a calibration curve. Exponential functions 
were fitted to experimental data and the parameters of best fit were used to calculate the 
initial rate of ATPe extinction, i.e. Apyrase activity. Results were expressed as μM/min. For 
apyrase t1/2 values were calculated as ln(2)/k, where k is the kinetic coefficient of the 
exponential function. 
 
2.11 Cell volume measurements 
Changes in cell volume were measured using the coulter counting principle with either Scepter 
2.0 (Merck Millipore Japan, Tokyo, Japan) or a Casy analyzer (Schärfe System, Reutlingen, 
Germany). 
2.11.1 Cell Scepter measurements 
The Scepter cell counter was used to assess volume of RBCs suspensions exposed to HlyA. 
Briefly, 100 L of 20 % RBCs suspensions were exposed at 37 °C to 100 L of HlyA in iso- or 
hyperosmotic media, in the absence or presence of different blockers. After 5 and 10 min of 
HlyA exposure, samples were diluted and aspirated using 40 µm tip sensors, according to the 
manufacturer’s recommendation. Cell counts and cell volume distributions were acquired. 
















(expressed as total volume, Vt) were obtained from the weighted arithmetic mean of each 
histogram. 
2.11.2Casy measurements 
Alternatively, cell volume was measured using a Casy cell analyzer. Briefly, 300 μL of 40 % RBCs 
suspensions were exposed to HlyA in isosmotic media, in the absence and presence of apyrase 
(10 U/mL). 10 μL of the suspensions were taken at different time of HlyA exposure and diluted 
400-fold before measurements. Cell volume values obtained were expressed as total volume 
(Vt).  
 
2. 12 Endothelial cell culture in biochips and flow adhesion assay 
Human micro vascular endothelial cell line 1 (HMEC-1) cells were seeded at 107 cells/mL in 
Vena8 Endothelial+ Biochips (Cellix Ltd, Dublin, Ireland) previously coated with 40 μL of 0.2% 
gelatin in PBS. Cells were then incubated at 37 °C for 24 h to allow cell attachment and 
cultured for 48 hs using a Kima pump (Cellix Ltd.). Mediium was changed via a peristaltic pump 
system every 2 hours with a 300 μL/min flow. Cells were then activated with TNFα (10 ng/mL) 
at 37 °C for 24 hours and medium was changed every 2 hours. RBCs were washed and 
resuspended in isosmotic medium supplemented with 0.5% BSA at 2% hematocrit. Adhesion 
assays were initiated by perfusion of the RBCs at a 0.2 dyn/cm² for 10 min. This was followed 
by 5-min of washes at 0.5, 1 and 2 dyn/ cm2. The whole process was controlled using the Exigo 
pumps and the Cellix software. Images were taken 1 min before wash using the Zeiss 
AxioObserver microscope, with a 10X objective. Images were acquired using the ZEN software. 
Adherent RBCs were counted from 6 representative areas. 
 
2.13 Microscopy 
Morphology of RBCs was studied by videomicroscopy of viable cells and by Scanning Electron 
Microscopy (SEM) of glutaraldehide fixed cells. 
2.13.1 Videomicrocopy. 
RBCs suspensions (1 % hematocrit) were exposed to vehicle, HlyA, ProHlyA or HlyAΔ914-936 at 
20 °C. Preparations were immediately mounted on slides and observed by light microscopy 
(Biotraza LCD XSP-167SP). Images were acquired for 30 min using a charge-coupled device 
camera at 100X magnification. Control samples were run with non-treated RBCs. 
2.13.2 Scanning Electron Microscopy 
RBCs were treated with HlyA or ProHlyA for 30 min and then fixed in 2.5% glutaraldehide. 
Fixed samples were then coated with graphite by thermal evaporation of charcoal (0.150 Torr 
at 50 Amp for 30 s) using a Desk Carbon Accessory coater (DENTON VACUUM). Coated samples 
were placed in a holder and observed by SEM (SJEOL model JSM-IT300-LV). Images were 
acquired with a Secondary Electron Detector at 30 kV, 10-30 spot size and work distance of 10 
mm at high vacuum. Control samples were run with non-treated RBCs. 
 
2.14 Deformability 
Deformability changes of RBCs treated with HlyA (or analog proteins) were analyzed by 
ektacytometry using a LoRRca MaxSis equipment (MechatronicsVR, Hoorn, Netherlands), 
















function of shear stress. The system has been described elsewhere in detail (44). Briefly, a laser 
beam is directed to RBCs suspended in polyvinylpyrrolidone (PVP), which are subjected to an 
osmotic gradient or to a gradient of shear stress, and the diffraction pattern produced by the 
deformed cells is analyzed by a microcomputer. Based upon the geometry of the elliptical 
diffraction pattern, an elongation index (EI) is calculated as: EI = (L−W)/(L+W), where L and W 
are the length and width of the diffraction pattern. An increased EI indicates greater cell 
deformation and hence greater RBC deformability. 
When EI was evaluated as a function of medium osmolarity (80-690 mosm/Kg), yielding 
characteristic osmoscan curves (Fig. 12 A). The assay was carried out using 250 μL aliquots of 
44 % RBCs suspensions exposed to HlyA at 37 °C. Samples were taken 2.5 and 3.5 min after 
treatment. Control samples were run with non-treated RBCs. 
From osmoscan curves five parameters were obtained (45): EI min (minimal EI of the curve), O 
min (osmolality at El min), El max (maximal El), O max (osmolality at El max) and O hyper 
(osmolality in the hyperosmotic region). The O min directly correlates with the osmolality 
producing 50 % hemolysis using a standard osmotic resistance test; EI max corresponds to the 
maximal elongation of the curve; O hyper corresponds to osmolality at 50 % of EI max and 
reflects the hydration state, increased intracellular viscosity secondary to osmotic water loss 
and hemoglobin concentration. 
When deformability was evaluated as a function of shear stress, a thin layer of RBCs 
suspended in PVP at 37 °C was placed between two concentric cylinders and shear stress (0.3 – 
30 Pascal) was applied. The assay was carried out with 25 μL of 44 % RBCs suspensions 
exposed to HlyA (or analog proteins) at 37 °C. Samples were taken 2.5 and 3.5 min after 
treatment. Control samples were run with non-treated RBCs. All measurements were carried 
out at 37 °C. 
Although deformability measurements were run in media without dextran, to compare results 
of these experiments with those on aggregability (see below), a few experiments were run in 
the presence of 3 % dextran 400. Both for shear stress curves and osmoscans, results were 
similar in the absence and presence of this compound (data not shown). 
 
2.15 Aggregability 
Aggregation properties of RBCs were determined at 37 °C by laser backscatter vs. time, using a 
LoRRca MaxSis equipment (MechatronicsVR, Hoorn, Netherlands). A syllectogram was created 
by plotting laser backscattered intensity (Isc) vs.time.  
RBCs suspensions (40 % hematocrit) were exposed to vehicle (controls), ProHlyA or HlyA for 5 
min at 22°C, , in the presence of 3% dextran 400 to promote aggregation. Samples were 
subjected to high shear for 2 s to dissociate pre-existing RBCs aggregates. Shearing was then 
stopped abruptly and the changes in lsc were monitored for another 2 min. 
 
2.16 Calcium content 
Intracellular calcium content of RBCs was assessed before and after exposure of HlyA or analog 
proteins. 
RBCs suspensions (0.3 % hematocrit) were loaded with 5 μM Fluo4-AM at 37 °C for 60 min, 
washed and resuspended in isosmotic medium. 100 μL of RBCs suspensions were loaded in 96-
well black-walled, clear-bottom plates (Corning, Inc). Real time fluorescence measurements 
















Inc., Winooski, VT, USA). The fluorescent signal was recorded in each well simultaneously 
every 5 s (λexc: 485 ± 20 nm; λemission 528 ± 20 nm). After 10 min of stable baselines, RBCs were 
exposed to vehicle or HlyA (or analog proteins) in the absence or presence of different 
blockers. At the end of the experiment, 5 μM ionomycin was added as positive control. Results 
were normalized to baseline values and expressed as relative Cytosolic Calcium Content 
(Ft/F0), i.e., the ratio of fluorescence signal at t (Ft) over fluorescence signal before treatment 
(F0). 
 
2.17 Assessment of membrane externalization of phosphatidylserine (PS) 
The exposure of PS to the outer membrane leaflet of RBCs was measured using lactadherin 
binding by flow cytometry using a FACS Canto II flow cytometer (BD Biosciences). Briefly, RBCs 
suspensions (40 % hematocrit) were incubated at 37 °C and exposed to no toxin (control), HlyA 
or ProHlyA for 2, 3.5, 5 and 10 min. Samples were then centrifuged (10,000 x g for 10 s) and 
resuspended in isosmotic medium to a 400-fold dilution; 100 μL of this suspension was then 
incubated with 100 μL of FITC-conjugated lactadherin (1/25 dilution, Cryopep Enterprise, 
Montpellier, France) for 10 min at room temperature in the dark. Next, samples were diluted 
2-fold in isosmotic medium for measurement. Data was analyzed using the FlowJo software 
(Tree Star). Results were expressed as percentage of positive RBCs and mean fluorescence 
intensity. In parallel experiments, RBCs were exposed to 10 µM A231875 (a Ca2+i ionophore) as 
positive controls. 
 
2.18 Membrane Potential (Vm) 
The effects of HlyA on Vm of HlyA-treated RBCs were estimated by monitoring changes in 
fluorescence intensity using DiBaC4(3) (46) as described previously (47). Briefly, RBCs 
suspensions were diluted in isosmotic medium with 1 µM DiBaC4(3) to a final 0.03 % 
hematocrit. Fluorescence intensities were quantified at 515 nm (λ excitation = 490 nm) every 3 
s with continuous stirring at 100 rpm in a PerkinElmer LS-55 spectro fluorometer (PerkinElmer 
Ltd., Beaconsfield, United Kingdom). RBCs were exposed to HlyA after 5 min of cell 
stabilization. Values of Vm were expressed as a fluorescence ratio (Ft/F0), where F0 represents 
the signal of the 5 min baseline and Ft denotes the signal at given time point.  
In separated experiments, calibrations of the fluorescence signal were performed. Briefly, RBCs 
loaded with DiBaC4(3) were centrifuged at 12000 × g for 30 s and then resuspended at 0.03 % 
hematocrit in isosmolar solutions with varying K+ concentrations (1.5 to 150 mM, Table 3). 
Fluorescence was registered for 5 min and then 2 μM valinomycin was added. Results were 
expressed as relative fluorescence intensity (Ft/F0), where F0 denotes the signal obtained in 
the absence of valinomycin and Ft represents the signal at the stationary state after 
valinomycin addition. All measurements were performed at 37 °C. 
 
2.19 Mean mesenteric arterial bed pressure (MABP) 
Adult male Sprague-Dawley rats (250 ± 30 g) were anaesthetized with Isofluorane (5 and 2 % 
for induction and maintenance, respectively). 
The small bowel (jejunum and ileum) with the vascular pedicle (superior mesenteric artery and 
















The whole preparation was placed in an organ bath filled with Krebs solution and kept at 37 °C. 
The superior mesenteric artery and the portal vein were cannulated with polyethylene tubing 
and perfused with isosmotic medium at 37 °C (1 mL/min) for 10 min in order to eliminate all 
rat erythrocytes. A pressure transducer (Letica TRI-201) was connected to the mesenteric 
artery inflow line and changes were measured continuously. The signals from the force 
transducers were amplified and driven into an analog–digital board (DT16EZ, Data Translation, 
Marlboro, MA, USA) mounted in a computer. On-line recordings and files for later processing 
were obtained with the software Labtech Notebook Pro (Laboratory Technology, Wilmington, 
MA, USA). Then the preparation was washed with isosmotic medium and subsequently 
perfused with HlyA- or ProHlyA-treated RBCs (10% hematocrit) at 37 °C (1 mL/min). Under 
each condition, the MABP was constantly monitored and samples of fluids leaving from portal 
vein were taken at 2-min intervals for ATP and Hb assessment. 
 
2.20 Rat mesentery histology 
Following perfusion of RBCs suspension under the different treatments (i.e., controls, HlyA and 
ProHlyA treated RBCs), samples of the rat small intestine were taken for histological 
examination of the blood vessels. Briefly, samples were fixed in 10 % formaldehyde solution 
for 72 h, dehydrated in ascending grades of ethyl alcohol (70 %, 80 %, 90 % and 95 %), then 
cleared in terpinol and embedded in paraffin and sectioned at 6 mm. The sections were 
deparaffinized in xylene, embedded in descending grades of ethyl alcohol, washed in water 
and then stained with hematoxylin and eosin. 
 
2.21 Ethics Statement 
Human blood was obtained by venipuncture from healthy volunteers the day each study was 
performed. The study has been approved by the COBIMED (Committee for Bioethics and 
Investigation, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, protocol 43) and 
by CEIC (Committee for Ethics on Clinical Investigation, Facultad de Farmacia y Bioquímica, 
Universidad de Buenos Aires EXP-UBA: 0048676/2017), according to the requirements of the 
Declaration of Helsinki and the Argentinean legislation concerning Public Health (laws 25326 
and 26529). Written informed consent was given by the donors. 
Animal handling followed and conformed to the animal welfare guidelines according to NIH 
(USA) standards. The study has been approved by the Faculty ethical committee for the use of 
animals in biological research (protocol P04-01-2017). 
 
2.22 Data analysis 
Statistical significance was determined using one-way analysis of variance followed by a 
Turkey–Kramer test of multiple comparisons. A P value < 0.05 was considered significant. 


















The effects of HlyA and structural mutants proteins on ATPe regulation were first studied on 
isolated RBCs suspended in isosmotic medium. In addition, to account for responses in a more 
in vivo context, some experiments were carried out using RBCs challenged by osmotic 
gradients, shear forces, and perfused through adhesion platform or a rat isolated mesentery 
bed. 
 
3.1 HlyA-dependent ATPe regulation of RBCs 
In the absence of hemolysis ATPe kinetics depends on the dynamic balance between non lytic 
ATP release by protein conduits of viable cells (increasing [ATPe]) and ATPe hydrolysis by one 
or more ectonucleotidases (decreasing [ATPe]), i.e. ectoATPase activity. In addition, hemolysis 
induced by HlyA may release ATP and ATPases. These intracellular enzymes, when released in 
the extracellular space, could hydrolyze ATPe. It follows an assessment of each of these 
processes potentially affecting ATPe regulation. 
 
3.2 HlyA induced ATP release 
ATPe release was evaluated by off-line luminometry at 37 °C using a 10 % hematocrit. HlyA 
concentration was adjusted to result in 0.5 % hemolysis after 5 min of exposure (Suppl. Fig. 1). 
Paired samples were taken to assess hemolysis by measuring extracellular Hb (see Methods). 
RBCs exposure to HlyA produced a non-linear accumulation of ATPe, with [ATPe] amounting to 
27.8 ± 8.6 µM after 10 min exposure, i.e., a 36-fold increase over control values (Fig. 1 A). This 
increase correlated with activation of hemolysis from 0.20 ± 0.03 to 9.02 ± 2.26 % (Fig. 1 A). 
Prior to calculating lytic and non-lytic ATP release, a characterization of ATPases affecting ATPe 
regulation was performed. 
 
Fig. 1. Effects of HlyA on [ATPe], ATPe hydrolysis and hemolysis of RBCs. 
(A) Kinetics of [ATPe] and hemolysis of HlyA-treated RBCs. RBCs suspensions (10% hematocrit) were 
exposed to HlyA at 37 °C for 2-10 min and [ATPe] (grey bars, left axis) and hemolysis (white bars, right 
axis) were quantified. At t=0, RBCs were treated with vehicle in the absence of HlyA. Results are 
expressed as µM ATPe and as percentage of hemolyzed RBCs (%Hemolysis) with respect to the total 
number of RBCs. Results are mean values ± S.E.M. (t=0 min, N=20, n=16; t=2-4 min and 6-8min, N=4, 
n=8; t=5 min and 10, N=8, n=16). (B) ATPe hydrolysis by EctoATPase and Intracellular ATPase activities. 
EctoATPase activity (ATPaseEA) and ATPase activity of intracellular ATPases (ATPaseIA) were estimated as 
a function ATP (µM). Each point of the curves represents the rate of ATP extinction (µM/min). For 
EctoATPase activity (close triangles), 2.22x108 viable cells were used, while intracellular ATPase activity 
was performed with hemolyzates from 2x106 cells (white circles) or 107 cells (white squares). Dashed 
lines represent the fitting of linear functions to experimental data. Results are mean values ± S.E.M. (C) 
Relative contribution of ATP fluxes to ATPe kinetics of HlyA-treated RBCs. Experimental data on ATPe 
kinetics and hemolysis (A), ectoATPase and intracellular ATPase activities (B) were fed into a 
mathematical algorithm to estimate the relative contribution of these processes to [ATPe] when RBCs 
were exposed to HlyA for 0-10 min. Details of the mathematical procedure are given in the Suppl. File. 
ATPeL=ATPe produced by hemolytic release of intracellular ATP; ATPeIA= ATPe consumed by intracellular 
ATPases released by hemolysis; ATPeEA=ATPe consumed by EctoATPase activity. ATPeNL= ATPe produced 
by non-lytic release of intracellular ATP, calculated by using the algorithm. Inset: Data from main graph 
during the first 5 min. 
Numbers of determinations (n) from independent preparations (N) are indicated. HlyA concentration 


















Changes in [ATPe] were detected by off-line luminometry. EctoATPase activity was assessed by 
adding exogenous ATP (2—153 µM) to a suspension of RBCs in the absence of toxin, and 
following the rate of ATPe decay. Values of initial decay rates for each [ATPe] were used to 
build a substrate curve. EctoATPase activity vs. [ATPe] was approximated by a linear function 
with slope of the curve (KEA, see Eq. 6 of Suppl. File) amounting to 0.052 min-1 (Fig. 1 B). 
To assess intracellular ATPase activity, RBCs were lysed and homogenized. Exogenous ATP (1-
120 µM) was added to the reaction mixture containing aliquots of homogenate samples in the 
absence of toxins, and the rate of [ATPe] decay was followed. Repeating this procedure for 
each [ATP] allowed to build a substrate curve. ATPase activity vs. [ATP] was approximated by a 
linear function with slope of the curve (KIA, see Eq. 7 of S1 File) amounting to 0.014 min-1 (Fig.1 
B). 
Results showed that intracellular ATPase activity increased with the volume of the 
homogenate -representing the number of dead cells- and with [ATP]. 
Having experimentally determined ATPe kinetics, ectoATPase activity, and intracellular ATPase 
activity of HlyA-exposed RBCs (HlyA-RBCs), we built a simple numerical algorithm (see Suppl. 
File) to calculate the dynamic contribution of each ATP flux to [ATPe] kinetics. 
 
3.4 Modeling ATPe kinetics 
When modeling ATPe kinetics, ATP efflux and ATPe hydrolysis were treated as ATP fluxes. 
Thus, following HlyA exposure, [ATPe] may increase by lytic (JL, i.e. lytic flux) and non-lytic (JNL, 
i.e. non-lytic flux) ATP release, and decrease by hydrolysis due to ectoATPase activity (JEA, i.e. 
ectoATPase flux) or intracellular ATPases of hemolyzed RBCs (JIA, i.e intracellular ATPase flux). 
ATPe kinetics was expressed as: 
d[ATPe]/dt= JNL+JL-JEA-JIA  
This equation was fed with experimental data as follows: 
d[ATPe]/dt, JL, JEA and JIA were estimated by fitting empirical functions to experimental data of 
Figs. 1 A-B. We then used these functions to calculate the magnitudes of the fluxes, and their 
contribution to [ATPe], at any time from 0-10 min. A detailed description of the calculations is 
given in the Suppl. File. The only unknown flux was JNL, whose kinetics was derived using the 
other fluxes and the values of d[ATPe]/dt. 
Following this procedure, results of Figs. 1 A-B could be expressed as in Fig. 1 C, where the 
relative contribution of each flux to ATPe kinetics can be seen. 
ATPe kinetics was dominated by simultaneous lytic and non-lytic release of ATP. ATPe 
hydrolysis by JEA and JIA was relatively low, although their strength increased with time, thus 
reducing [ATPe] by 23 % at 10 min post stimulus. 
The lytic component (ATPL) was relevant at all times of toxin exposure, and it amounted to 32 
% of total ATPe at 10 min post stimulus, vs. 50 % for the contribution of non-lytic ATPe (ATPNL) 
release to total ATPe. 
 
3.5 Non-lytic HlyA-dependent ATP release 
Lytic ATP release did not fully account for the observed increase of [ATPe] in HlyA-RBCs, since a 
simultaneous non-lytic ATP efflux (JNL) was activated. Both JL and JNL were relatively low at first, 
but steeply increased beyond 7 min of toxin exposure. 
By considering the intracellular ATP content of RBCs (32) and the number of viable cells at any 
















the first 5 min of toxin treatment the contribution of JNL to [ATPe] kinetics required <1 % of 
intracellular ATP. Thus it did not impose an energetic burden to RBCs. In the late phase of the 
response (8-10 min), however, the required intracellular ATP steeply increased to approx. 11 
%. 
 
Table 1. Time course of ATPNL, and its relationship to intracellular ATP 
Time (min) ATPeNL (μM) % ATPeNL/ATPintra 
0 0.16 0.07 
2 0.43 0.19 
4 1.16 0.51 
5 1.92 0.85 
6 3.17 1.4 
8 8.64 4.04 
10 23.58 11.39 
ATPNL is shown as ATPNL values (µM), taken from Fig 1 C, or relative (%) to the experimentally 
determined intracellular ATP content (ATPintra). In the experimental conditions, intracellular ATP of 
RBCs amounts to 2.05 mM (32). 
 
The mechanisms mediating this flux were studied. RBCs were exposed to HlyA protein analogs 
differing slightly in structure with HlyA. In addition, the effects of HlyA on ATP loaded 
liposomes were tested. Finally, RBCs were pre-incubated with carbenoxolone (CBX), a well-
known pnx1 inhibitor, prior to HlyA challenge. 
 
3.6 HlyA and protein analogs 
To gain insight into structure-function relationships, RBCs were exposed to ProHlyA and 
HlyA∆914-936. ProHlyA is the un-acylated precursor of HlyA, known to be hemolytically 
inactive (49,50), while HlyA∆914-936 is a HlyA deletion protein lacking a short segment 
(residues 914–936) known to bind glycophorins on the surface of RBCs membranes (26). 
To assess ATP release, RBCs were exposed to these toxin analogs for 5 or 10 min at a 
concentration ten times that used for HlyA. Results showed a small, but non-significant [ATPe] 
increase with either compounds (Fig. 2 A). Nevertheless, HlyA∆914-936 and ProHlyA were 
functional, in that they induced crenation of RBCs (see section 3.10). Moreover, although HlyA 
acutely increased Ca2+i (a signal of eryptosis), HlyA∆914-936 and ProHlyA were unable to 
induce increases of Ca2+i content (see section 3.10). Thus both fatty acids covalently bound to 
the toxin, converting ProHlyA into HlyA, and the protein segment responsible for glycophorins 
binding on RBCs membrane are important structural components of HlyA enabling ATP 
release. 
 
Fig. 2. ATPe and hemolysis from RBCs exposed to HlyA and protein analogs and ATP release from ATP-
loaded liposomes. 
(A) Effects of HlyA and protein analogs on [ATPe] and hemolysis of RBCs. RBCs suspensions (10 % 
hematocrit) were exposed to HlyA, ProHlyA or HlyAΔ914-936 at 37 °C. At 5 and 10 min samples were 
taken to quantify [ATPe] (grey bars, left axis) and hemolysis (white bars, right axis). Controls were 
assessed using RBCs suspensions treated with vehicle. Results are expressed as µM ATPe and as 
percentage of hemolyzed RBCs (% Hemolysis) with respect to the total number of RBCs. Results are 
mean values ± S.E.M. (N=8, n=16) (*, significant vs. Control; &, significant vs mutants; ns, non-significant 
















increments as a function of liposome number for different HlyA concentrations. Liposomes (1.7x1010, 
1.7x1011 and 2.5x1011) were exposed to 11 ng/μL (white bars) and 22 ng/μL (grey bars) of HlyA and ATP 
release was measured by on-line luminometry. Results are expressed as µM ATPe and are mean values ± 
S.E.M. (N=2, n=4) of [ATPe] at 20 min post stimulus. Results were obtained from similar ATPe kinetics 
curves shown in Suppl. Fig. 2 B. (C) Effects of carbenoxolone on HlyA-induced ATP release and 
hemolysis. RBCs suspensions (10 % hematocrit) were pre-incubated for 10 min with or without 100 μM 
carbenoxolone (CBX), followed by HlyA addition. At 5 and 10 min samples were taken to quantify [ATPe] 
(grey bars, left axis) and hemolysis (white bars, right axis). Controls were assessed using RBCs 
suspensions treated with vehicle. Results are expressed in µM ATPe and as percentage of hemolyzed 
RBCs (% Hemolysis). Results are mean values ± S.E.M. (N=4, n=8) (*, significant vs. Control; &, significant 
vs. CBX treatment).  
Numbers of determinations (n) from independent preparations (N) are indicated. HlyA concentration 
was adjusted as in Fig. 1. Concentrations of ProHlyA or HlyAΔ914-936 were 10 times the concentration 
used for HlyA. P< 0.05 was considered significantly different. 
 
3.7 Liposomes 
It was previously argued that HlyA per se was able to oligomerize and form a pore capable of 
releasing ATP, so that no endogenous ATP conduit would be needed to explain non-lytic ATP 
release from RBCs (10). 
Based on this hypothesis, we decided to test HlyA dependent ATP release by on-line 
luminometry on liposomes made of PC:SM:Cho (2:1:1), a lipid composition similar to that of 
the external monolayer of RBCs (51). Liposomes were loaded with 50 mM ATP. To compare 
results with those using RBCs, extravesicular ATP was denoted as ATPe. 
In the absence of HlyA, basal ATPe remained constant at 0.47 μM, showing no ATP leak. 
Addition of 300 μg/mL digitonin to disrupt liposomes, on the other hand, led to a strong 
increase of [ATPe] (Suppl. Fig. 2 A). 
Exposure to HlyA induced an acute, 1.3-fold increase of [ATPe] (Suppl. Fig. 2 B). ATPe release 
correlated directly –but non-linearly- with liposome number and HlyA concentration (Fig.2 B). 
However, to make ATPe detectable relatively high HlyA concentrations (2-5-fold higher than 
that used with RBCs) and a high intravesicular [ATP] (24-fold higher than intracellular [ATP] of 
RBCs) had to be used. To compare HlyA induced ATP efflux in liposomes vs RBCs, maximal 
values of [ATPe] increase (at 10 min post-stimulus for RBCs, Fig. 1 A and at 20 min post-
stimulus for liposomes, Fig.2 B) were normalized per surface area. Results showed that 
normalized efflux (µM/µm2) amounted to 8.50x10-10 (RBCs) and 9.55x10-11 (liposomes). I.e., 
RBCs exhibited a 9-fold higher ATP release, even when –as mentioned above- liposomes 
contained a much higher intracellular ATP concentration and were exposed to a higher HlyA 
concentration.  
 
3.8 Effect of carbenoxolone (CBX) 
The small increase of [ATPe] induced by exposing liposomes to HlyA suggest that the toxin per 
se is not mediating most of ATP efflux of RBCs. Thus, we investigated whether HlyA induced 
ATP release of RBCs can be inhibited by CBX, an inhibitor of the ATP conduit pnx1. Accordingly, 
RBCs were pre-incubated with 100 µM CBX and [ATPe] was determined at 5 and 10 min post-
stimulus. Results showed that CBX + HlyA reduced 43-67 % of [ATPe] increase and 43-61 % of 
hemolysis (Fig. 2 C) induced by HlyA alone. 
By using the mathematical algorithm (see Modeling ATPe kinetics above and Suppl. File), the 
influence of CBX on both the lytic and non-lytic fluxes on ATPe kinetics could be calculated, 

















3.9 Interaction between cell volume and [ATPe] 
Our previous accounts have shown that [ATPe] and Vt can be mutually regulated in RBCs 
exposed to amphipatic peptides (33,52). Thus, a series of experiments were conducted to 
study the relationship between these two variables in HlyA-RBCs. 
Results of Fig. 3 A showed the kinetics of Vt challenged by HlyA. Vt was measured by the 
Coulter Counter principle. Cells very slightly shrunk during the first min post stimulus, followed 
by continuous swelling up to 40 % of initial control values. 
 
Fig. 3. Effect of HlyA on RBCs volume (Vt). ATPase activity of Apyrase 
(A) Time course of Vt of HlyA-exposed RBCs. RBCs suspensions (40 % hematocrit) were pre-incubated 
for 10 min with or without 10 U/mL of apyrase (Apy) prior to HlyA exposure. Inset: Data from main 
graph during the first 2.5 min post stimulus. Results are mean values ± S.E.M. (N=1, n=3). (B) Volume of 
HlyA-exposed RBCs. RBCs suspensions (10 % hematocrit) were pre-incubated at 37 °C for 10 min with or 
without 10 U/mL Apy, followed by HlyA exposure for 5 and 10 min. Control values refer to RBCs exposed 
to vehicle. Results are mean values ± S.E.M. (Control, N=13, n=20; HlyA, N=9, n= 15; HlyA-Apy, N=5, 
n=8). (C-D) Kinetics of ATP hydrolysis by Apyrase. The rate of ATP hydrolysis by apyrase (5-20 U/mL) 
was determined by following the decay of [ATP] 3 µM (C) and 30 µM (D) by on-line luminometry. Results 
are mean values (N=1, n=2). The continuous lines represent fittings of exponential functions to 
experimental data.  
Numbers of determinations (n) from independent preparations (N) are indicated. HlyA concentration 
was adjusted as in Fig. 1. 
 
Shape dynamics assessed by optical microscopy showed morphological transitions from 
birefringent discocyte (i.e., normal shape of control RBCs) to echinocyte (spiculated shape) to 
spherocyte (nearly spherical) (see section 3.10). 
Pre-incubation with excess apyrase (10 U/ml), a well-known ATPe scavenger (53), did not 
change Vt kinetics (Fig. 3 A), thus suggesting that ATPe was not affecting Vt. This was 
unexpected since we observed before that ATPe can activate RBCs swelling (33). We then 
focused on the late swelling phase of the response to HlyA, analyzing average values of Vt 
taken from volume distribution profiles (Vt histograms, see Suppl. Fig. 4 A). 
As expected from Vt kinetics (Fig. 3 A), HlyA induced a 46 % and 60 % Vt increase after 5 and 
10 min of toxin exposure, respectively (Fig. 3 B), while in ProHlyA treated RBCs (Pro-RBCs)and 
non-treated RBCs (c-RBCs) no swelling could be detected (Suppl. Fig. 4 B). 
As previously observed, pre-incubation with apyrase did not alter swelling of HlyA-RBCs (Fig. 3 
B). Thus, either [ATPe] had no effect on Vt increase, or apyrase was not efficiently removing 
ATPe under the experimental conditions. We thus used on-line luminometry to assess the 
capacity of apyrase to consume exogenous ATP in the absence of RBCs. Using 0.03-30 µM ATP 
(covering the range of endogenous [ATPe] observed in Fig. 1), apyrase dose-dependently (5-80 
U/mL) decreased [ATPe], with t1/2 ranging from 0.01-0.31 min (Fig. 3 C-D and Suppl. Fig. 
5).Results implied that ATPe removal by the enzyme was not instantaneous, so that substantial 
ATPe can still be present when using apyrase in RBCs suspensions treated with HlyA. Thus, as 
an alternative to removing ATPe, we blocked the effect of the nucleotide on specific purinergic 
receptors. In particular, we hypothesize that changes in Vt could be controlled by P2X receptor 
activation by ATPe. In RBCs functional P2X2 and P2X7 subtypes were reported (54,55). 
Accordingly, cells were incubated with 600 nM A438079 and 200 nM A740003 (two P2X7 
blockers) or 10 µM NF110 (a blocker of P2X1-3) before toxin addition. Results showed the 
















[ATPe] (Fig. 4 A and B, respectively), and a 53 % (5 min post stimulus)-66 % (10 min post 
stimulus) reduction of hemolysis (Fig. 4 C and D, respectively) when compared with the effects 
of the toxin alone. 
 
Fig. 4. Effect of P2X receptors on [ATPe], cell volume and hemolysis of HlyA-exposed RBCs 
RBCs suspensions (10 % hematocrit) were used to measure [ATPe] (grey bars) and hemolysis (white 
bars) at 5 min (A) and 10 min post stimulus (B). Cell volume (Vt) was measured in separate samples (C). 
Before HlyA addition (for 5 or 10 min), RBCs suspensions were pre-incubated for 10 min in the absence 
(controls) or presence of the following P2X antagonists: 200 nM A740003 (P2X7), 600 nM 438079 
(P2X7), 10 μM NF110 (P2X1-2). For hemolysis experiments at 5min HlyA exposure, additional treatments 
were used, i.e, RBCs were pre-incubated with [10 μM NF110 + 200 nM A740003] or [100 μM CBX + 10 
μM NF110 + 200 nM A740003]. 
A-B: Results are mean values ± S.E.M. (N=4, n=8). (*, significant vs. Control; &, significant vs. inhibitors). 
C: Results are mean values ± S.E.M. (Control, N=13, n=20; HlyA, N=9, n=15; Inhibitors, N=5, n=8). (*, 
significant vs. Control; &, significant vs. HlyA). Numbers of determinations (n) from independent 
preparations (N) are indicated. HlyA concentration was adjusted as in Fig. 1P< 0.05 was considered 
significantly different. 
 
Co-incubation with 10 μM NF110 + 200 nM A740003 or 100 μM CBX + 10 μM NF110 + 200 nM 
A740003 did not reduce hemolysis beyond reductions obtained with the inhibitors applied 
separately (Fig. 4 C). 
Since inhibition of HlyA dependent [ATPe] increase was similar for A438079 and A740003, and 
was already observed after 5 min, we tested the effects of A438079 and NF110 on Vt 
folllowing 5 min exposure to the toxin. It can be seen that NF110 significantly reduced 80 % of 
the swelling response caused by HlyA, while A438079 produced a similar reduction trend, 
although results were not significant (Fig. 4 E). 
As a final test for the reciprocal regulation of swelling on ATP release, RBCs were exposed to 
HlyA dissolved in a slight hyperosmotic medium (Hyper-HlyA). During toxin exposure, final 
medium osmolarity was 10 % over isosmotic values (i.e., 330 mOsm). As observed in Fig. 5 A, 
swelling was reduced by 70-96 % in Hyper-HlyA, as compared to HlyA under isosmotic 
conditions. Hyper-HlyA also decreased ATPe release and hemolysis of RBCs (Fig 5 B-C). 
 
Fig. 5. Effect of hyperomoslarity on cell volume, ATPe and hemolysis of HlyA-exposed RBCs 
RBCs suspensions (10 % hematocrit) were used to measure [ATPe] (grey bars) and hemolysis (white 
bars) (A). Cell volume (Vt) was measured in separate samples (B). Cells were exposed to HlyA dissolved 
in isosmotic medium (300 mOsm) or hyperosmotic medium (330 mOsm) at 37 °C, for 5 and 10 min. 
Control experiments were run in isosmotic medium in the absence of HlyA. Results are mean values ± 
S.E.M. (A: N= 4, n= 8; B: Control, N=13, n=20; HlyA, N=9, n=15; Hyper, N=4, n=5) (*, significant vs. 
Control; &, significant vs. hyperosmotic treatment). 
Numbers of determinations (n) from independent preparations (N) are indicated. HlyA concentration 
was adjusted as in Fig. 1.P< 0.05 was considered significantly different. 
 
3.10 Calcium content, cell shape, PS exposure and membrane potential 
To explain mechanisms allowing the observed changes in Vt, ATPe and hemolysis, additional 
parameters were monitored. 
Shrinking was postulated to be triggered by calcium increase, and this should correlate with 
crenation and PS exposure. The biphasic Vt response, on the other hand, could be due to 
changes in the net flux of osmolyte ions, in which case changes in the membrane potential 
















Accordingly, under HlyA, our results showed an acute increase of Ca2+i concentration (1.3-2.2-
fold; Fig. 6 A-C), which could not be blocked by NF110 or A74003 (Fig. 6 B), increased crenation 
followed by swelling (Fig. 7 B-C), and irreversible PS externalization (Fig. 6 D and Table 2), 
which are typical features of eriptosis (56). 
 
Fig. 6. Effects of HlyA and protein analogs on calcium content and phosphatidylserine (PS) 
externalization. 
(A-B) Cytosolic Calcium Content. RBCs suspensions (0.3 % hematocrit) were loaded with Fluo4-AM and 
exposed to ProHlyA or HlyA (A); additionally, before HlyA exposure RBCs suspensions were pre-
incubated for 10 min with the following P2X antagonists: 200 nM A740003 (P2X7), 10 μM NF110 (P2X1-
2) or 10 μM NF110 + 200 nM A740003. (B). Calcium content was measured after exposure to HlyA or 
ProHlyA. Ionomycin was used as positive control. Controls were assessed with vehicle.. (C) Kinetics of 
calcium content of HlyA-RBCs. RBCs suspensions (0.3 %) were loaded with Fluo4-AM and exposed to 
HlyA. Time changes in fluorescence intensity were recorded every 5 s for 10 min. Results are mean 
values ± S.E.M. (A-B: Control, N= 8, n= 20; ProHlyA, N=8, n=13; HlyAΔ914-936, N=8, n=13; HlyA, N=8, 
n=46. C: N=3, n=12; NF110, N=4, n=8; A740003, N=4, n=8; NF110+A740003, N=4, n=8) (*, significant vs. 
Control; &, significant vs. ProHlyA and HlyAΔ914-936). (D) Phosphatidylserine (PS) exposure as function 
of time for HlyA-treated RBCs. RBCs suspensions (10 % hematocrit) were incubated at 37 °C and 
exposed to HlyA for 2-10 min. PS exposure was expressed as percentage of positive control and are 
means values ± S.E.M. (N=4, n=5). Control values refer to RBCs exposed to vehicle.  
Numbers of determinations (n) from independent preparations (N) are indicated. P< 0.05 was 
considered significantly different. 
 
Table 2. Values of phosphatidylserine exposure after different treatments. 
Control ProHlyA HlyA A23175 
0.56 ± 0.09 0.61 ± 0.05 28.04 ± 0.95 93.60 ± 1.77 
RBCs were treated with ProHlyA, HlyA or ionophore A23187 (positive control). Results were obtained 
after incubation RBCs for 10 min under the different conditions. Results are expressed as percentage of 
positive controls and are means values ± S.E.M. (N= 4, n=5). Numbers of determinations (n) from 
independent preparations (N) are indicated. 
 
Moreover, the membrane potential (Vm) showed an acute hyperpolarization followed by 
depolarization (Fig. 8 A-B and Table 3), with roughly similar kinetics to that observed for Vt 
(Fig. 3 and correlation plot of Fig. 8 C). 
 
Fig. 7. Effects of HlyA and protein analogs on RBCs morphology 
(A-D) Live cell imaging. Light microscopy images of RBCs suspensions exposed to vehicle (A), HlyA 
(0.011 and 0.132 ng/μL; B-C), ProHlyA (1.32 ng/μL; D) or HlyAΔ914-936 (1.32 ng/μL; E) at 20 °C.. (F-H) 
SEM micrographs. RBCs were treated with vehicle (F), HlyA (G) or ProHlyA (H) for 30 min at 20 °C. 
Samples were fixed in 2.5% glutaraldehyde and coated with graphite. Images were acquired with a 
Secondary Electron Detector at 30 kV and high vacuum. (F (a) scale =20 μm, (b) scale = 5 μm; G (a-b) 
scale = 5 μm, different field; H (a) scale = 10 μm, (b) scale = 2 μm). 
 
When RBCs were exposed to ProHlyA or the deletion protein HlyA∆914-936, only crenation 
was observed (Fig. 7 D-E) with no changes in Ca2+i concentration (Fig. 6 B). Moreover, ProHlyA 
produced no PS externalization (Fig. 6 D and Table 2), although changes in morphology could 
be verified at higher spatial resolution using SEM. That is, exposure of RBCs to ProHlyA induced 
the formation of echinocytes (Fig. 7 H), with no hemolysis. On the other hand, HlyA treated 
RBCs exhibited different morphological changes, where echinocytes and spherocytes could be 

















Fig. 8. Membrane potential (Vm) of HlyA-exposed RBCs 
RBCs suspensions were loaded at 37 °C with DiBaC4(3) and the effects of HlyA on Vm were tested. 
Results are expressed as florescence relative to basal values (untreated RBCs): Ft/F0. (A) Kinetics of Vm 
RBCs exposed to HlyA.. From 0-5 min, relative basal Vm time course was measured. At 5 min RBCs were 
exposed to HlyA (N=3, n=5), and Vm was recorded. The arrow indicates addition of HlyA. (B) Relative 
Fluorescence Intensity of DiBaC4(3) as function of K+ concentration ([K+]). DiBaC4(3) loaded RBCs were 
exposed to isosmolar solutions with increased [K+] in the presence of valinomycin. (C) Correlation 
between Vt and Vm. Data from A was plotted as Vm against values of Vt from Fig. 3 A at different times 
of HlyA exposure. Numbers of determinations (n) from independent preparations (N) are indicated. 
 












HlyA-induced PS externalization, as observed in Fig. 6 D, can lead in vivo to adhesion of RBCs to 
vascular endothelial cells (VECs). Thus we tested whether HlyA was able to induce RBCs 
adhesion to VECs. RBCs suspensions were perfused under controlled flow in adhesion 
platforms coated with HMEC cells. Fluid flow was initially low (0.2 dyn/cm2) to allow adhesion, 
and then increased in 5 min steps to 0.5, 1 and 2 dyn/cm2 to induce detachment. Irrespective 
of the treatment (control, ProHlyA or HlyA), adhesion was higher at low flow (0.2 dyn/cm2), 
and decreased steadily with flow increments. As seen in Fig. 9 B and Table 4, in HlyA-RBCs 
adhesion to VECs was strongly increased, as opposed to c- and Pro-RBCs  (Fig 9. A and C). 
However, adhesive forces were weak, as increments in flow induced a high detachment (Fig. 9, 
panels from left to right). 
 
Fig. 9. Effect of HlyA on RBCs adhesion to endothelial vascular cells 
Representative images of RBCs adhesion to HMEC. RBCs suspensions (2 % hematocrit) treated with 
vehicle (A), HlyA (B) or ProHlyA (C) were perfused under controlled flow through adhesion platforms 
coated with HMEC cells. Fluid flow was initially low (0.2 dyn/cm2) to allow adhesion, and then increased 
in 5 min steps to 0.5, 1 and 2 dyn/cm2 to induce detachment. Red arrows indicate adhered RBCs. 
 
Table 4. Number of adhered RBCs to HMEC cells 
Control ProHlyA HlyA 
10 ± 3 5 ± 2 1506 ± 740 
Control refers to RBCs-treatment with vehicle. Results are mean values ± S.E.M. (N=2, n=3). Numbers of 
determinations (n) from independent preparations (N) are indicated. 
 
3.12 ATP release of RBCs in a rat mesentery model 
HlyA-RBCs exhibited enhanced ATP release by lytic and non-lytic processes. Here, we 
















RBCs are continuously perfused through a rat mesenteric vascular bed. This is a heterologous 
organ system where the entire vascular pedicle and the small intestine remain intact (57). 
Mean mesenteric arterial bed pressure (MABP, estimated as pressure in mmHg) was 
continuously recorded, and intravascular levels of ATP (ATPiv) and free Hb (to estimate lytic 
ATP release) were measured at discrete times in perfusate samples that leave the arterial bed 
through the portal vein. 
Suppl. Fig. 6 A showed a picture of the model system where the superior mesenteric artery 
and the portal vein were cannulated for vascular perfusion. Details on the setup are given in 
Methods. Krebs Ringer solution at 37 °C was perfused at 1 mL/min. After MABP stability, 10 % 
RBCs suspensions were perfused at the same rate, and MABP was constantly monitored. 
As a control for the functional integrity of the smooth muscle cells and the endothelium of the 
arterial bed, we observed that 10 µM noradrenaline strongly increased MABP due to smooth 
muscle contraction, while with 20 µM acetylcholine a significant decrease was observed, 
suggesting a functional endothelium (Suppl. Fig. 6 B); basal values of MABP were obtained 
when buffer perfusion washed out these compounds. 
In separate experiments, the mesentery was perfused with assay media containing ProHlyA or 
HlyA, in the absence or presence of RBCs, and ATPiv and MABP were measured. 
ATPiv was 0.13 ± 0.08 μM with isosmotic medium perfusion, and 0.29 ± 0.14 μM in the 
presence of RBCs (Fig. 10 A). Perfusion of free HlyA or ProHlyA in the absence of RBCs 
produced minor changes on ATPiv (0.31 ± 0.11) (Fig. 10 B) while perfusion of ProHlyA plus 
RBCs further increased ATPiv to 1.19 ± 0.42 µM, with hemolysis amounting to 0.57 ± 0.38 % 
after 10 min of perfusion (Fig. 10 C). However, when HlyA and RBCs were co-perfused, ATPiv 
increased from 2.01 ± 0.47 µM at t=1-2 min, to 27.28 ± 7.26 µM at t=9-10min, and hemolysis 
increased from 4 to 33 % (Fig. 10 D). Parallel determinations of ATPiv and Hb allowed us to 
estimate the relative contribution of lytic and non-lytic mechanisms of RBCs ATP release when 
RBCs were flowing inside the arterial bed. As seen in Fig. 10 D, the non-lytic component of ATP 
release was the major component explaining ATPiv. 
 
Fig. 10. ATP release of RBCs in a rat mesenteric vascular bed and its effect on vascular pressure 
Vehicle (buffer) or RBCs suspensions (10 % hematocrit) were perfused through a rat mesentery 
preparation. Mean mesenteric arterial bed pressure (MABP) was recorded and samples of the 
perfusates were collected at different times (T1-T5) for assessment of ATP. The latter was denoted as 
intravascular ATP (ATPiv). (A) Perfusion of vehicle or control RBCs suspensions (c-RBCs). (B) Perfusion of 
either ProHlyA or HlyA dissolved in buffer, in the absence of RBCs. (C-D) Perfusion of RBCs suspension in 
the presence of either ProHlyA (ProHlyA-RBCs, C) or HlyA (HlyA-RBCs, D). Samples of the perfusates 
were collected for assessment of hemoglobin and ATP. Hemoglobin concentration was used to estimate 
lytic ATP (ATPL). The difference between [ATPiv] and [ATPL] was calculated and denoted as non-lytic ATP 
(ATPNL). A stacked graph was built to show the contribution of lytic and non-lytic ATP release from RBCs 
to [ATPiv]. (E) Effect of HlyA-treated RBCs on MABP. Assessment of MABP, estimated as Force in mmHg 
was continuously recorded. 
A-D: Results are mean values ± S.E.M. (A, C and D: N=2; B: N=3). E: Results are mean values ± S.E.M. of 
the highest values registered for each treatment. (N=9, c-RBCs; N=6, HlyA-RBCs; N=3, HlyA-RBCs) (*, 
significant vs. c-RBCs and Pro-RBCs). 
Numbers of independent preparations (N) are indicated. Concentration of ProHlyA was 10 times the 
value for HlyA. P< 0.05 was considered significantly different. 
 
On the other hand, in RBCs and Pro-RBCs, MABP values were 18.14 ± 3.32 and 17.32 ± 5.22 
















(38.3 ± 7.8 mmHg) compared to RBCs alone (Fig. 10 E), suggesting and additional contractile 
effect induced by HlyA. Thus, we tested in separate experiments the effect of Hb and 
exogenous ATP to evaluate their separate effects on vessel contraction. Results showed that 
high Hb (>10 μM) can induce vasoconstriction, while exogenous ATP did not significantly affect 
MABP (Suppl. Fig. 6 C-D). 
In experiments using RBCs in the absence and presence of HlyA, tissue samples were taken to 
evaluate the morphology of RBCs inside the vascular system. Tissue sections were stained with 
hematoxylin-eosine (58) and observed by light microscopy. In the absence of toxins, RBCs of 
arteries, capillaries and veins showed a conserved morphology. With HlyA, on the other hand, 
RBCs showed altered morphology and apparent clumping (Fig. 11). 
 
Fig. 11. Histology of rat mesenteric vascular bed. 
Histology of the rat mesentery preparations from Fig. 10. Several samples of the jejunum were taken. 
The sections were stained with hematoxylin and eosin and the vessels were assessed by light 
microscopy  
(A-B) Rat mesentery perfused with control RBCs (c-RBCs, treated with vehicle). (A) shows an artery 
(magnified on a) and a  vein (magnified on b) containing RBCs. (B) shows a capillary (magnified on c). (C-
H) Rat mesentery perfused with HlyA-exposed RBCs (HlyA-RBCs). Pictures show an artery (C), veins (D-
E) and cappilaries (F-H) containing RBCs.and  
The paraffin embedded preparations are representative from several experiments. 
 
3.13 Deformability 
Deformability changes of c-, Pro-, HlyA∆914-936- and HlyA-RBCs were analyzed by 
ektacytometry, which quantifies the magnitude of cell elongation as a function of applied 
osmolality (80-690 mosm/kg), or as a function of shear stress (0.2-30 Pa). 
When the elongation index (EI) was measured at gradually changing osmolality but constant 
shear stress, it produced characteristic osmoscan curves shown in Fig. 12 A. 
 
Fig. 12. Effect of HlyA and protein analogs on RBCs deformability. 
 (A) Deformability vs osmolality. Deformability (elongation index, EI) of RBCs as a function of applied 
osmolality (80-690 mOsm/Kg) at constant shear stress (30 Pa). Before measurements, RBCs suspensions 
(40% hematocrit) were exposed to HlyA, ProHlyA, HlyAΔ914-936 or vehicle (Control), for 2.5 min or 3.5 
min. (B) Deformability vs shear stress. EI values of RBCs as function of shear stress (0.2-30 Pa), at 
constant iso-osmolarity. Prior to measurements, RBCs suspensions (44% hematocrit) were exposed for 5 
min to ProHlyA (N=4), HlyA (N=8), HlyAΔ914-936 (N=1) or vehicle (Control, N=9). Upper and lower 
panels show reconstructed-images of the shape of Control and HlyA-treated RBCs, respectively, at 
different values of shear stress. Results are mean values ± S.E.M. Numbers of independent preparations 
(N) are indicated. HlyA, ProHlyA and HlyAΔ914-936 concentrations were adjusted as indicated before. 
 
The maximum point of the curves (EI max) represents the osmolality at which cells have the 
highest deformability. EI can decrease on both arms of the curve by either a reduction in 
surface area-to-volume ratio (S/V) or an increase in intracellular viscosity (59). 
As expected, for c-RBCs the curve exhibited a maximum near 320 mOsM, suggesting that they 
deformed optimally in isosmolar conditions. Pro-RBCs and HlyA∆914-936-RBCs showed a 
similar response. In HlyA-RBCs the toxin time-dependently shifted the curve to the right. This is 
indicative of HlyA-RBCs increasing Vt and sphericity and reducing the cellular viscosity 
determined by the intracellular hemoglobin concentration. Thus a higher osmolality (O hyper) 

















In a second series of experiments, EI was tested as a function of shear stress in isosmotic 
conditions. C-RBCs, Pro-RBCs and HlyA∆914-936-RBCs showed a non-linear increase of EI as a 
function of shear stress. This is compatible with RBCs extending their long axis with the flow, as 
the shape changes from an oblate-like spheroid to a prolate-like ellipsoid (Fig. 12 B). HlyA-
RBCs, on the other hand, had a relatively low EI at all levels of applied shear stresses, probably 
reflecting that cells were not prone to form ellipsoids, as simulated images illustrate (insets of 
Fig. 12 B). 
 
3.14 Aggregability 
In typical syllectograms, a refraction index (Isc) depends on the interaction forces between two 
adjacent RBCs, which in turn vary with viscosity, cell shape and membrane damage. 
Experiments were run in the presence of dextran (400 kDa), which mimics viscous effect of 
plasma proteins. Aggregates are dispersed with increasing shear forces, and reform under low 
shear force conditions. In c- and Pro-RBCs, roughly similar syllectograms were obtained; an 
increase in Isc (upstroke) was observed when, after the rotor stopped, RBCs were assumed to 
retake their normal shape and orient randomly. This was followed by a decrease in Isc values 
when cells aggregated (Fig. 13 A). Pro-RBCs usually adopt an echinocyte-like shape (Fig. 7 D), 
which may induce higher interaction forces between pairs of cells, thereby explaining the 
higher Isc values a t =0. 
 
Fig. 13. Effect of HlyA on aggregability of RBCs 
(A) Syllectograms. Refraction index (Isc) vs time. Before measurements, RBCs suspensions (40 % 
hematocrit) were exposed to HlyA, ProHlya or vehicle (Control) for 5 min, an aggregability was 
measured in the presence of 3 % dextran 400 (400 kDa) by light scatter. Results are mean values ± 
S.E.M. (N=7). (B-D) Micrographies by optical microscopy of RBCs treated with vehicle (B), ProHlyA (C) 
and HlyA (D), in the presence of 3 % dextran 40X. 
Numbers of independent preparations (N) are indicated. 
 
In contrast, the HlyA-RBCs curve was flat. In line with osmoscans showing higher O hyper 
values (Suppl. Fig. 7) and the observed swelling (Fig. 3), HlyA-RBCs are assumed to be more 
spherical, thus decreasing contact area between adjacent cells and refracting the laser in a 
lesser extent, thereby yielding the observed small Isc values. HlyA-RBCs were not able to 
recover their normal shape, nor could they aggregate.  
To account for morphological changes, similarly treated RBCs suspensions containing dextran 
400 were observed by light microscopy at 40X magnification (Fig. 13 B-D), showing typically 
stacked RBC from c-RBC (Fig. 13 B); echinocyte-lyke shape from Pro-RBCs (Fig. 13 C), and 


















HlyA of uropathogenic strains of E. coli is known to interact with RBCs in the intravascular 
milieu, triggering ATP release and metabolic changes leading to hemolysis (19,60). In this 
context, the main goal of this study was to identify the key factors controlling ATPe kinetics of 
RBCs exposed to HlyA, and to explore how these changes influence the behavior of RBCs 
exposed to different environments mimicking several features found in vivo. Accordingly, we 
first assessed ATPe hydrolysis and intracellular ATP release, and its modulation by purinergic 
receptors and Vt, and then analyzed how HlyA affects metabolic and rheological properties of 
RBCs suspensions, the adhesion of RBCs to endothelial platforms, and ATP release of RBCs 
perfused through a heterologous mesentery. 
 
4.1 ATPe regulation 
Exposure of RBCs to low concentrations of HlyA led to acute ATP release and hemolysis. In 
addition, ATPe was hydrolyzed by intracellular ATPases of lyzed RBCs and ectoATPase activity 
of RBCs. By fitting a data driven model to experimental data of ATPe kinetics, lytic ATP release, 
ectoATPase activity and intracellular ATPase activity, we were able to calculate the non-lytic 
component of ATP release, and quantify the relative contribution of each of these processes to 
ATPe kinetics. 
This analysis showed that ATPe kinetics of HlyA-RBCs was mainly governed by simultaneous 
lytic and non-lytic ATP release. Enzymatic ATPe hydrolysis was relative low at acute exposures 
times. This is consistent with low hemolysis and therefore low ATPe hydrolysis by intracellular 
ATPases, together with relatively low ectoATPase activity, which is a feature of mature RBCs 
from mammalian species, including humans (32,42,61). There may be more than one 
ENTPDase accounting for ectoATPase activity (62,63), whereas no ectophosphatase activity 
was detected in RBCs (64). 
Despite low ATPe hydrolysis, since under HlyA exposure [ATPe] increases continuously and 
ectoATPase and intracellular ATPase activities are linearly dependent on [ATPe], their 
contribution to ATPe kinetics is higher at high incubation times, causing reductions of up to 22 
% at the end of the experiments. 
The contribution to ATPe hydrolysis by ectoATPase activity could be even higher since, as we 
showed before (42) ATP at the cell surface, where the active sites of ectonucleotidases are 
located, is 2.4 higher than bulk ATPe measured in RBCs assay medium. 
In addition to direct [ATPe] decrease by enzymatic hydrolysis, we and others have shown that 
the resulting ADPe can activate P2Y13 receptors mediating a decrease of cAMP content, 
coupled to reduced ATP release (29,33). Although, as show in this study, ATPe to ADPe 
conversion might be very low in RBCs, while ectoADPase activity is relatively high (64), in vivo 
intravascular ATP hydrolysis by plasma exoenzymes, ectonucleotidases of other blood cell 
types or the vascular wall might provide sufficient ADPe to promote inactivation of ATP release 
of RBCs (65). 
 
4.2 Non-lytic ATP release 
To characterize non-lytic ATP efflux (JNL), we first compared the effects of HlyA and ProHlyA, 
the un-acylated precursor of HlyA. In rabbit RBCs ProHlyA is able to insert into cell membranes 
















necessary for the toxin to become hemolytic (66). The observed absence of ATP release with 
ProHlyA in this study suggests that acylation is also important to trigger non-lytic ATP exit from 
RBCs. Although the role of toxin acylation remains unclear, studies on the effects of chemical 
denaturants, ANS binding and sensitivity to proteases suggest that HlyA –unlike ProHlyA- may 
expose intrinsically disordered regions mediating intracellular signaling leading to hemolysis 
(50,66). This is in line with our results showing that HlyA, but not ProHlyA, was able to 
irreversibly externalize PS and increase cytosolic Ca2+ of RBCs, two events coupled to eryptosis 
(67). Alternatively, FRET experiments using label toxins showed that HlyA, but not ProHlyA, 
was able to oligomerize on ghost erythrocytes membranes suggesting that these disordered 
regions might promote protein-protein interactions, controling the oligomerization of the toxin 
(68). An oligomer, in turn, should create a 2-3 nm pore capable of mediating ATP efflux from 
RBCs (69). However, the existence of such a pore has been challenged due to lack of direct 
evidence by electron microscopy or crystal structure analysis (24,25). 
Thus, to test if HlyA induced ATP release by direct interaction with the phospholipid 
membrane, with no other proteins involved, we exposed HlyA to liposomes loaded with ATP. 
We used liposomes composed of PC:SM:Cho mimicking the composition of the outer 
hemilayer of RBCs (51). This lipid mixture presents liquid order domains similar to the 
membrane microdomains involved in oligomerization and the lytic mechanism of the toxin 
(68,70). Although HlyA was reported to promote efflux of fluorochromes and even ATP from 
liposomes (10,71), the magnitude of this flux was not assessed. In our hands, using PC:SM:Cho 
liposomes, ATP efflux mediated by high HlyA concentrations was measurable, but very low, 
when compared to similar results using HlyA-RBCs. Thus, even if HlyA can indeed form an 
oligomeric pore liposomes, our results imply that the toxin is not forming an ATP conduit. 
Thus, it seems that HlyA effect on ATP release may require the interaction with endogenous 
membrane proteins of RBCs. HlyA was found to bind to N-linked oligosaccharides to their β2-
integrin receptors (72), raising the possibility that binding of the toxin to various cells might 
occur through the recognition of glycosylated membrane components, such as gangliosides 
and glycoproteins. We then exposed RBCs to HlyA∆914-936, a deletion analog protein unable 
to bind glycophorins, a highly abundant family of membrane proteins of RBCs. A previous 
study showed that HlyA∆914-936 was not hemolytic on RBCs, and that the peptide Trp914–
Arg936 had no lytic activity on RBCs, although it could bind to glycophorins in reconstituted 
liposomes (26). 
Again, as with ProHlyA, although HlyA∆914-936 induced RBCs crenation in the absence of Ca2+i 
increase, it neither alters [ATPe] nor hemolysis. In HlyA-RBCs, on the contrary, a steep acute 
Ca2+i increase correlated with a crenatocyte to spherocyte transition, followed by hemolysis. 
This means that, at least for RBCs, glycophorins seem important for HlyA activity, although 
other proteins might as well be interacting with the toxin. These results are also in agreement 
with the need of higher concentration of HlyA to induce detectable ATP release from 
liposomes. 
In looking for endogenous ATP transport systems, we analyzed the role of pnx1, an ubiquitous 
ATP conduit in cells (18). Particularly, we tested the effect of CBX, a glycyrrhetinic acid 
derivative known to inhibit pnx1 in a wide variety of cell types (73,74). Pnx1 was predicted to 
form four α-helical transmembrane domains exposing two extracellular loops, with multiple 
residues in the first extracellular loop mediating CBX dependent pnx1 inhibition (75). In RBCs, 
















swelling, hypoxia and beta adrenergic stimulation (32,42,75,76). However, in HlyA-RBCs the 
effects of CBX can be more complex since, as we observed in this study, CBX exposure led to a 
parallel inhibition of [ATPe] and hemolysis of HlyA-RBCs. This is compatible with the model of 
Fig. 14, since a decrease of JNL (by CBX blockage in this case) can diminish swelling and 
therefore decrease the extent of hemolysis.  
We then simulated the effect of CBX on ATP efflux of viable cells (i.e, JNL). Predictions showed 
that JNL is composed of two fluxes, a CBX-sensitive (presumably pnx1) and CBX-tolerant flux. 
CBX reduction of JNL was low in the early phase of toxin exposure (≈20 % at 5min), but high at 
late exposure times (≈80 % at 10 min) (Suppl. Fig. 3). 
 
4.3 Interaction between cell volume and [ATPe] 
Analyzing changes in Vt induced by HlyA is important for various reasons. First, HlyA activity in 
RBCs has been associated with changes in Vt (60). Second, hypo- and isosmotic swelling are 
strong inducers of non-lytic ATP release from RBCs (32,73,77), while excessive swelling can 
induce hemolysis, thereby activating lytic ATP efflux. Third, we observed before that treating 
RBCs with an amphipatic peptide induced interacting changes of [ATPe] and Vt (33). 
Results of this study showed that following HlyA exposure, RBCs slightly crenate and shrunk 
during the first min, followed by continuous swelling, which preceded a steep increase in 
hemolysis. 
As volume histograms (Suppl. Fig. 4), volume kinetics (Fig. 3 A) and morphology dynamics (Fig. 
7 B-C) show, the accompanying Vt and shape changes of RBCs are heterogeneous, both within 
a single RBCs sample, and between samples from different individuals. This is because RBCs, 
with its limited lifespan, represent an heterogeneous population expressing different 
molecules as they age. In addition, polymorphisms of P2X2-P2X7 receptors from RBCs (78) may 
contribute to variations in Vt kinetics of RBCs samples from different individuals, particularly in 
the context of the observed P2X dependent swelling. 
The biphasic Vt kinetics was also reported by Skals et al. (60), who showed that Ca2+i increase 
led to net KCl efflux mediated by KCa3.1 and TMEM16A channels, causing the shrinking phase, 
while subsequent swelling was assumed to be caused by sodium uptake. An early phase 
dominated by K+ conductance, followed by a late phase dominated by Na+ conductance, is 
compatible with our results showing a hyperpolarization followed by a depolarization of the 
membrane potential, with roughly similar kinetics to that of Vt. 
Since swelling per se is known to activate ATP exit of RBCs (32,73), we tested the extent to 
which HlyA induced ATP release depends on the observed swelling, and the underlying 
causative relationships linking changes in Vt and [ATPe]. 
Next, we analyzed the extent to which swelling promotes ATP release. When HlyA was added 
in a hyperosmotic medium to counteract swelling, ATPe release was highly inhibited. 
Interestingly, according to osmoscans, hyperosmotic conditions allowed HlyA-RBCs to regain 
elongation of untreated cells. Thus, swelling mediated most of HlyA triggered ATP release. We 
then tested whether ATPe could affect swelling. We first found that pre-incubation with excess 
apyrase, an ATPe remover (30,53), did not alter swelling. However, experiments testing 
apyrase activity in the absence of cells showed that, even if this enzyme reduced [ATPe] dose-
dependently, ATPe was still present in the medium for several minutes. This transient presence 
of ATPe could be sufficient to trigger purinergic signaling. In particular, ATPe is the only natural 
















(54,55) . P2X7 receptors are more abundant than P2X2 on RBCs (54), but exhibit much lower 
affinity for ATP (79). 
Activation of these receptors may lead to the net transport of cations altering intracellular 
osmolarity and therefore Vt (80). Pre-incubation with antagonists of either P2X7 or P2X1-2, 
reduced HlyA dependent [ATPe] increase by 52-73 %, and hemolysis by 53-66 %. Thus, as with 
CBX, these blockers inhibited both the lytic and the non-lytic component of ATP release. 
Moreover, P2X blockage strongly reduced swelling. Thus P2X receptors are working as a 
bridge, connecting swelling with activation of ATP release. The fact that P2X antagonists were 




Although RBCs do not adhere to vascular endothelial cells under physiological conditions, 
adherence occurs in many pathologies associated with vascular occlusion (67,81). During UPEC 
infection, when HlyA is produced and released in the intravascular space, the onset of 
inflammatory processes may up-regulate various adhesive molecules of endothelial cells (60), 
while eryptosis induced by HlyA, with concomitant PS externalization (as observed in this 
study), might turn RBCs more adhesive. This possibility is particularly important in the context 
of ATPe regulation of RBCs (analyzed in (82)), since we observed before that adhesion of these 
cells to chemically different adherent molecules positively modulates the activation of ATP 
release by swelling (32). To mimic this scenario, we perfused HlyA-RBCs at various controlled 
flows through artificial vessels coated with activated HMEC cells. Adhesion of HlyA-RBCs was 
very high at low flow. However, adhesive forces were weak, as increments in flow led to 
almost full detachment from HMEC cells. This means that, under HlyA exposure, PS 
externalization of RBCs might correlate with their higher adhesion to vascular endothelial cells, 
particularly in regions of low flow. However weak adhesion should not lead to vascular 
occlusion. 
 
4.5 Rat mesenteric vascular bed. Monitoring lytic and non-lytic ATP release 
Since HlyA can induce ATP exit by lytic and non-lytic mechanisms, can this response be 
observed in a vascular system? To answer this question, we used a rat mesentery model where 
the entire mesenteric vascular system and the irrigated small intestine remained intact, and 
HlyA-RBCs (vs. c- and Pro-RBCs) were perfused at controlled flow. In this heterologous system 
intravascular pressure can change, and mechanical forces due to peristaltic movements can 
occur. 
When HlyA-RBCs were perfused, significant increases of intravascular ATP (ATPiv) and Hb were 
observed, while Pro-RBCs induced much lower responses. As observed before when assessing 
[ATPe] of isolated RBCs suspensions, [ATPiv] increments were due to lytic and non-lytic 
components of ATP release. Since no damage to the endothelium occurred and HlyA alone did 
not change [ATPiv], the observed elevated [ATPiv] should derive mostly from intracellular ATP 
of RBCs. 
Higher [ATPiv] increases than observed could be expected in vivo, where hematocrits are 
about 3-fold higher than that used in our experimental setup. Moreover, the accumulated 
ATPiv can underestimate ATP release by HlyA-RBcs, since in the vascular environment the 
















and phosphatases of plasma, blood cells and the vascular endotelium (55,62,65), generating 
various di- and trinucleotides, and adenosine. These compounds may bind purinergic receptors 
mediating a variety of responses (55,83). In particular, ATPe to ADPe conversion, promoting 
elevated intravascular ADP, might activate thrombocytes, so that HlyA might potentiate 
thrombocyte aggregation and pro-coagulation, thereby leading to thrombosis episodes (10). In 
addition, as our group and others have shown before, E. coli can take up and metabolize 
exogenous ATP (84,85), a process incrementing the energetic status of bacteria. Thus, since 
intravascular UPEC produce HlyA, some of these processes might be relevant during 
progression of the infection. 
 
4.6 Deformability and aggregability of HlyA-RBCs 
RBCs acutely crenated when challenged by ProHlyA or HlyA. In addition HlyA, unlike ProHlyA, 
induced increments of cytosolic Ca2+ and PS externalization. Moreover, the mutually activating 
loop coupling increments of [ATPe] and Vt triggered irreversible swelling. All these changes 
may have altered the rheological properties of HlyA-RBCs, with consequences on blood flow. 
We thus monitored changes in deformability when HlyA-RBCs were exposed to shear stress or 
osmolality gradients. These stimuli are relevant in vivo, since RBCs are mobile cells exposed to 
mechanical forces when passing through small capillaries of the circulation and/or to osmotic 
gradients, especially in the kidney (86). Additionally we monitored HlyA-RBCs aggregability, 
since plasma proteins may render RBCs more liable to aggregate, particularly under low flow, 
causing vascular obstruction. 
Osmoscan curves were roughly similar for c- Hly Δ914-936- and Pro-RBCs. However, in HlyA-
RBCs, a significant right-shift of the osmoscan was observed, suggesting increased sphericity 
and swelling, and consequently reduced cellular viscosity. 
We then tested deformability as a function of shear stress. C-, HlyAΔ914-936- and Pro-RBCs 
exhibited large scale deformations, implying that the long axis of the cell extended with 
increased shear rates. In contrast, HlyA-RBCs displayed low deformability under similar 
conditions, which agrees well with the increment of ceramide contents in the outer leaflet of 
RBC membrane treated with the toxin, as previously demonstrated (20). Thus, HlyA-RBCs 
should be less capable to deform in narrow vessels, and as swollen cells more fragile to 
hypotonic stress. On the other hand, less deformable cells exposing PS may foster engulfment 
by phagocytes and potential clearance from the circulation (87). 
We then turned our attention to HlyA-RBCs aggregation. The tendency of RBCs to aggregate is 
an important determinant of blood viscosity. Aggregates are dispersed with increasing shear 
forces, and reform under low-flow conditions. Thus, in vivo aggregation affects the fluidity of 
blood, especially in the low-shear regions of the circulatory system (88,89). 
In syllectograms, c- and Pro-RBCs behaved roughly similar. I.e., basal Isc values were 
compatible with complete disaggregation at moderate shear rate and upstroke signal was 
compatible with RBCs recovering their normal shape and orientating randomly. This was 
followed by a time dependent decrease of Isc, reflecting aggregation. In this and other studies 
(50) Pro-RBCs were shown to adopt an echinocyte shape, which may induce higher interaction 
forces between pair of cells and thus explain the higher Isc values at t=0. 
In contrast, HlyA-RBCs syllectograms were flat, suggesting no changes in shape during 
















histograms showing swelling, HlyA-RBCs are assumed to be more spherical, thus decreasing 
contact area between adjacent cells, which may explain the observed reduced aggregation. 
 
4.7 Summarizing main findings 
Main results are depicted in Fig. 14. HlyA is activated by acylation of ProHlyA (1). The acylated 
moiety, as well as the glycophorin binding site of HlyA (absent in HlyA∆914-936) proved to be 
important for toxin activity (2). HlyA triggered simultaneous lytic and non-lytic ATP release (3), 
both using isolated RBCs, or RBCs suspensions flowing through a rat mesentery model,  leading 
to increased [ATPe]. This increase was in part counteracted by ATPe hydrolysis due to 
ectoATPase activity (4), and to ATPase activity of lysed cells (5). Binding of ATPe to P2X (6) 
triggered progressive swelling (7), which correlates with higher cell sphericity and lower 
deformability under osmotic gradients and shear stress, and low aggregability in viscous 
media. Low swelling activated mainly non-lytic ATP release, while high swelling produced 
hemolysis, leading to lytic ATP release and increases of MABP under flow. Swelling and 
hemolysis transduce into further increases of [ATPe], closing the signaling circuit. 
 
Fig 14: Regulation of ATPe in HlyA-exposed RBCs, and its modulation by cell volume and hemolysis 
Exposure to HlyA induces ATP release by lytic (JL) and non-lytic (JNL) mechanisms, causing [ATPe] 
increase, which is partially counteracted by ATPe hydrolysis due to ectoATPase (JEA) and intracellular 
ATPase (JIA) activities. ATPe activates P2X receptors coupled to cell swelling (Vt). Swelling below a critical 
volume Vc (Vt<Vc) activates JNL, favoring a higher symmetry (Fig 12) and lower aggregability (Fig. 13) of 
RBCs. Values of Vt>Vc lead to hemolysis and activation of JL; likewise, hemolysis can release intracellular 
ATPases, thereby activating JIA, which decreases [ATPe]. Finally, in a mesenteric system, hemolysis can 
increase intravascular pressure (MABP). 
The effects described above are absent when RBCs are treated with ProHlyA and HlyAΔ914-936. 
ATPi and ATPe denote intracellular and extracellular ATP, respectively. 
 
Hemolysis provided two processes ameliorating the effects of the loop; dying cells will 
decrease the amount of cells activating non-lytic ATP release and simultaneously release 
intracellular ATPases capable of decreasing [ATPe]. According to the scheme cell death, by 
promoting [ATPe] increase, can signal P2X receptors of surviving cells, modulating the 
reciprocal regulation of ATPe and Vt. 
To the extent that P2X blockers break the signaling loop promoting RBCs hemolysis, they –or 
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 α-hemolysin induces ATP release by lytic and non-lytic mechanisms. 
 α-hemolysin requires interaction with membrane proteins to induce ATP release. 
 α-hemolysin induces reciprocal regulation of cell volume and ATP release, mediated by 
P2X receptors 
 α-hemolysin induces lytic and non-lytic ATP release of erythrocytes perfussed through 
a mesentery. 
 α-hemolysin induces shrinkage followed by irreversible swelling and high adhesivity of 
erythrocytes to endotelial cells. 
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